Staurenghi, Giovanni

Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data

Spaide, R. F., Jaffe, G. J., Sarraf, D., Freund, K. B., Sadda, S. R., Staurenghi, G., Waheed, N. K., Chakravarthy, U., Rosenfeld, P. J., Holz, F. G., et al. (2020) · Ophthalmology

Retinal Diseases and TreatmentsRetinal Imaging and Analysis

Cited by 824

Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study

Holz, F. G., Amoaku, W., Donate, J., Guymer, R. H., Kellner, U., Schlingemann, R. O., Weichselberger, A., & Staurenghi, G. (2011) · Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 413

RETINAL ANGIOMATOUS PROLIFERATION: Natural History and Progression of Visual Loss

VIOLA, F., MASSACESI, A., ORZALESI, N., RATIGLIA, R., & STAURENGHI, G. (2009) · Retina

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 79

Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration

Callanan, D., Kunimoto, D., Maturi, R. K., Patel, S. S., Staurenghi, G., Wolf, S., Cheetham, J. K., Hohman, T. C., Kim, K., López, F. J., et al. (2018) · Journal of Ocular Pharmacology and Therapeutics

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 73

How to manage COVID-19 vaccination in immune-mediated inflammatory diseases: An expert opinion by IMIDS study group

Ferretti, F., Cannatelli, R., Benucci, M., Carmagnola, S., Clementi, E., Danelli, P., Dilillo, D., Fiorina, P., Galli, M., Gallieni, M., et al. (2021) · Frontiers in Immunology

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 39